Market Announcement
Mindsight AI Launches Temigis: A New Era of Intelligence for Life Sciences Leaders.
SYDNEY, AUSTRALIA — Mindsight AI today announced the soft launch of Temigis, a pioneering AI-first life sciences intelligence platform designed to redefine how commercial, regulatory, and strategic leaders synthesise complex data into actionable outcomes.
Developed by experienced software engineers and life sciences data experts at Mindsight AI, Temigis has been designed to bridge the gap between disparate raw data sets and strategic decision-making by providing consultant-grade analysis and insights in seconds. Leveraging advanced generative intelligence and a standardised, AI-optimised data layer, the platform surfaces profound insights across regulatory, clinical, and commercial domains, delivering consultant-grade analysis that previously required weeks of manual research, in hours.
Why Now?
Whilst preparing for the official launch of our Temigis ANZ platform, we became concerned that recent outages to the Medsafe Product/Application Search database (operated by New Zealand Medicines and Medical Devices Safety Authority), the primary public tool for searching medicines registered for sale in New Zealand, would create a significant gap for life sciences professionals. In response, Mindsight AI accelerated development of New Zealand tools and data and is now making Temigis NZ available at no cost for a limited period of time to support the industry in its 'hour of need'.
The Temigis NZ platform provides access to Medsafe data, updated monthly via the NZULM dataset, with purpose-built tools for Sponsor Search, Product Search, Ingredient Search, new Medicine Applications and Approvals, all delivering executive-ready analysis in seconds.
Over the coming weeks New Zealand pricing information will be added to enhance the insights available, followed by expansion to include Australian data.
The Temigis interface: Clean, intuitive, and built for complex data synthesis.
What is Temigis?
Temigis is a pharmaceutical intelligence platform built specifically for the New Zealand and Australian life sciences markets which unifies disparate data sources into a single, standardised AI-friendly database. Unlike general AI tools such as ChatGPT or Gemini, every Temigis response is grounded in up-to-date regulatory data. We like to think of it as a specialist consultant who knows the ANZ pharmaceutical market on demand.
"The life sciences sector is drowning in data but starving for insight," said Leighton Howard, Founder of Mindsight AI. "Temigis is our response to the problem of disparate, inconsistent data sources in life sciences, a single platform that not only has access to the latest information, but understands and interprets the clinical, commercial, and regulatory nuances required by today's leaders."
Pricing
For a limited time, Temigis NZ Lite is available at no cost, and includes limited monthly tokens. Users can upgrade to higher subscription tiers to access increased token limits. Register now to lock in free access at temigis.com.
About Mindsight AI
Mindsight AI is the premier intelligence partner across the health, aged care, and life sciences sectors. By combining deep industry expertise with frontier AI engineering, Mindsight helps organisations move from fragmented data to decisive action, with speed and confidence. Temigis is its flagship platform.